Download PDF
Thromb Haemost 2010; 103(06): 1145-1151
DOI: 10.1160/TH09-12-0848
Review Article
Schattauer GmbH

The role of thrombin and protease-activated receptors in pain mechanisms

Paul S. García
1   Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia, USA
,
Amitabh Gulati
1   Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia, USA
,
Jerrold H. Levy
1   Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia, USA
› Author Affiliations
Further Information

Publication History

Received: 18 December 2009

Accepted after minor revision: 27 January 2010

Publication Date:
22 November 2017 (online)

    Permissions and Reprints

Summary

As our knowledge of the mechanisms underlying the sensation of pain continues to expand, researchers are constantly searching for novel therapeutic targets. One such novel pain pathway involves thrombin and its associated protease-activated receptor (PAR). Besides its traditional role in haemostasis, thrombin has multiple roles in both the central and peripheral nervous system including activation of microglia, regulation of neuronal death and neurite outgrowth, and influencing the transmission of pain signals in the nociceptive circuitry. Eventually therapeutic modalities directed at these targets could provide novel therapeutic approaches for treating chronic pain. The thrombin-associ-ated PARs also have roles in inflammation, neurodevelopment, and conducting pain, both in conjunction with thrombin and independently. Recent laboratory evidence suggests that the PARs can attenuate pain mediated by the enteric nervous system in animal models (for example in pancreatitis and colitis). This review highlights several pathways in the mediation of pain sensation that can be influenced by thrombin.

Keywords

Thrombin - protease activated receptor - pain - hemostasis - coagulation - inflammation
 

  • References

  • 1 Scholz J, Woolf CJ. Can we conquer pain?. Nat Neurosci 2002; 05 Suppl 1062-1067.
    CrossrefPubMedGoogle Scholar
  • 2 Argoff CE. et al. Multimodal analgesia for chronic pain: rationale and future directions. Pain Med 2009; 10 (Suppl. 02) S53-66.
    CrossrefPubMedGoogle Scholar
  • 3 Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009; 10: 895-926.
    CrossrefPubMedGoogle Scholar
  • 4 Seybold VS. The role of peptides in central sensitization. Handb Exp Pharmacol 2009; 194: 451-491.
    PubMedGoogle Scholar
  • 5 Miller RJ. et al. Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol 2009; 194: 417-449.
    PubMedGoogle Scholar
  • 6 Russell FA, McDougall JJ. Proteinase activated receptor (PAR) involvement in mediating arthritis pain and inflammation. Inflamm Res 2009; 58: 119-126.
    CrossrefPubMedGoogle Scholar
  • 7 Bunnett NW. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain. Semin Thromb Hemost 2006; 32 (Suppl. 01) 39-48.
    PubMedGoogle Scholar
  • 8 Santilli F, Davi G. Thrombin as a common downstream target blocking both platelet and monocyte activation. Thromb Haemost 2009; 101: 220-221.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Stassen JM. et al. The hemostatic system. Curr Med Chem 2004; 11: 2245-2260.
    CrossrefPubMedGoogle Scholar
  • 10 Martorell L. et al. Thrombin and protease-activated receptors (PARs) in atherothrombosis. Thromb Haemost 2008; 99: 305-315.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Dugina TN. et al. Effect of synthetic peptide thrombin receptor agonist encapsulated in microparticles based on lactic and glycolic acid copolymer on healing of experimental skin wounds in mice. Bull Exp Biol Med 2004; 138: 463-46.
    CrossrefPubMedGoogle Scholar
  • 12 Donovan FM. et al. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci 1997; 17: 5316-5326.
    CrossrefPubMedGoogle Scholar
  • 13 Patwardhan AM. et al. PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor. Pain 2006; 125: 114-124.
    CrossrefPubMedGoogle Scholar
  • 14 Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res 2004; 114: 321-327.
    CrossrefPubMedGoogle Scholar
  • 15 Fredenburgh JC. et al. Modes and consequences of thrombin’s interaction with fibrin. Biophys Chem 2004; 112: 277-284.
    CrossrefPubMedGoogle Scholar
  • 16 Di Cera E. Thrombin interactions. Chest 2003; 124 (Suppl. 03) 11S-17S.
    CrossrefPubMedGoogle Scholar
  • 17 Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev 2007; 21: 131-142.
    CrossrefPubMedGoogle Scholar
  • 18 Allen GA. et al. Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost 2004; 02: 402-413.
    CrossrefPubMedGoogle Scholar
  • 19 Wolberg AS. Thrombin generation assays: understanding how the method influences the results. Thromb Res 2007; 119: 663-665.
    CrossrefPubMedGoogle Scholar
  • 20 Turgeon VL. et al. Thrombin: a neuronal cell modulator. Thromb Res 2000; 99: 417-427.
    CrossrefPubMedGoogle Scholar
  • 21 Turgeon VL. et al. Activation of the protease-activated thrombin receptor (PAR)-1 induces motoneuron degeneration in the developing avian embryo. J Neuropathol Exp Neurol 1999; 58: 499-504.
    CrossrefPubMedGoogle Scholar
  • 22 Smirnova IV. et al. Thrombin is an extracellular signal that activates intracellular death protease pathways inducing apoptosis in model motor neurons. J Neurobiol 1998; 36: 64-80.
    CrossrefPubMedGoogle Scholar
  • 23 Faraut B. et al. Thrombin reduces MuSK and acetylcholine receptor expression along with neuromuscular contact size in vitro. Eur J Neurosci 2004; 19: 2099-2108.
    CrossrefPubMedGoogle Scholar
  • 24 Gill JS. et al. Thrombin induced inhibition of neurite outgrowth from dorsal root ganglion neurons. Brain Res 1998; 797: 321-327.
    CrossrefPubMedGoogle Scholar
  • 25 Suo Z. et al. Thrombin: a potential proinflammatory mediator in neurotrauma and neurodegenerative disorders. Curr Drug Targets Inflamm Allergy 2004; 03: 105-114.
    CrossrefPubMedGoogle Scholar
  • 26 Kyrle PA. et al. Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatment. Thromb Haemost 1997; 77: 685-689.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Nishino A. et al. Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 1993; 10: 167-179.
    CrossrefPubMedGoogle Scholar
  • 28 Motohashi O. et al. Hirudin suppresses the invasion of inflammatory cells and the appearance of vimentin-positive astrocytes in the rat cerebral ablation model. J Neurotrauma 1997; 14: 747-754.
    CrossrefPubMedGoogle Scholar
  • 29 Lee KR. et al. Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg 1996; 84: 91-96.
    CrossrefPubMedGoogle Scholar
  • 30 Turgeon VL, Houenou LJ. The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system. Brain Res Brain Res Rev 1997; 25: 85-95.
    CrossrefPubMedGoogle Scholar
  • 31 Sokolova E, Reiser G. Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases. Thromb Haemost 2008; 100: 576-581.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 32 Vu TK. et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-1068.
    CrossrefPubMedGoogle Scholar
  • 33 Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004; 84: 579-621.
    CrossrefPubMedGoogle Scholar
  • 34 Nystedt S. et al. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 1994; 91: 9208-9212.
    CrossrefPubMedGoogle Scholar
  • 35 Ishihara H. et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 1997; 386: 502-506.
    CrossrefPubMedGoogle Scholar
  • 36 Kahn ML. et al. A dual thrombin receptor system for platelet activation. Nature 1998; 394: 690-694.
    CrossrefPubMedGoogle Scholar
  • 37 Xu WF. et al. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 1998; 95: 6642-6646.
    CrossrefPubMedGoogle Scholar
  • 38 Carreno-Muller E. et al. Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia. J Neurochem 2003; 84: 1201-1214.
    CrossrefPubMedGoogle Scholar
  • 39 Choi SH. et al. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J Neurosci 2005; 25: 4082-4090.
    CrossrefPubMedGoogle Scholar
  • 40 Gingrich MB. et al. Potentiation of NMDA receptor function by the serine pro-tease thrombin. J Neurosci 2000; 20: 4582-4595.
    CrossrefPubMedGoogle Scholar
  • 41 Zeng F. et al. Enhancement of NMDA receptor sensitivity by thrombin and its relationship with tissue transglutaminase. Zhonghua Nei Ke Za Zhi 2005; 44: 668-671.
    PubMedGoogle Scholar
  • 42 Coughlin SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 2005; 03: 1800-1814.
    CrossrefPubMedGoogle Scholar
  • 43 Cenac N. et al. Proteinase-activated receptor-1 is an anti-inflammatory signal for colitis mediated by a type 2 immune response. Inflamm Bowel Dis 2005; 11: 792-798.
    CrossrefPubMedGoogle Scholar
  • 44 Jesmin S. et al. Temporal changes in pulmonary expression of key procoagulant molecules in rabbits with endotoxin-induced acute lung injury: elevated expression levels of protease-activated receptors. Thromb Haemost 2004; 92: 966-979.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 45 Mule F. et al. Evidence for the presence of functional protease activated receptor 4 (PAR4) in the rat colon. Gut 2004; 53: 229-234.
    CrossrefPubMedGoogle Scholar
  • 46 Megyeri M. et al. Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function. J Immunol 2009; 183: 3409-3416.
    CrossrefPubMedGoogle Scholar
  • 47 Hirose T. et al. Involvement of ASIP/PAR-3 in the promotion of epithelial tight junction formation. J Cell Sci 2002; 115: 2485-2495.
    PubMedGoogle Scholar
  • 48 Saito T, Bunnett NW. Protease-activated receptors: regulation of neuronal function. Neuromolecular Med 2005; 07: 79-99.
    CrossrefPubMedGoogle Scholar
  • 49 Cottrell GS. et al. Protease-activated receptor 2: activation, signalling and function. Biochem Soc Trans 2003; 31: 1191-1197.
    CrossrefPubMedGoogle Scholar
  • 50 Fang M. et al. Thrombin inhibits NMDA-mediated nociceptive activity in the mouse: possible mediation by endothelin. J Physiol 2003; 549: 903-917.
    CrossrefPubMedGoogle Scholar
  • 51 Tomimatsu Y. et al. Proteases involved in long-term potentiation. Life Sci 2002; 72: 355-361.
    CrossrefPubMedGoogle Scholar
  • 52 Kuroda R, Kawabata A. Pain information pathways from the periphery to the cerebral cortex. Yakugaku Zasshi 2003; 123: 533-546.
    CrossrefPubMedGoogle Scholar
  • 53 Vergnolle N. et al. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci 2001; 22: 146-152.
    CrossrefPubMedGoogle Scholar
  • 54 de Garavilla L. et al. Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br J Pharmacol 2001; 133: 975-987.
    CrossrefPubMedGoogle Scholar
  • 55 Green BT. et al. Intestinal type 2 proteinase-activated receptors: expression in opioid-sensitive secretomotor neural circuits that mediate epithelial ion transport. J Pharmacol Exp Ther 2000; 295: 410-416.
    PubMedGoogle Scholar
  • 56 Cenac N. et al. Proteinase-activated receptor-2-induced colonic inflammation in mice: possible involvement of afferent neurons, nitric oxide, and paracellular permeability. J Immunol 2003; 170: 4296-4300.
    CrossrefPubMedGoogle Scholar
  • 57 Nguyen C. et al. Colitis induced by proteinase-activated receptor-2 agonists is mediated by a neurogenic mechanism. Can J Physiol Pharmacol 2003; 81: 920-927.
    CrossrefPubMedGoogle Scholar
  • 58 Fiorucci S, Distrutti E. Role of PAR2 in pain and inflammation. Trends Pharmacol Sci 2002; 23: 153-155.
    CrossrefPubMedGoogle Scholar
  • 59 Asfaha S. et al. Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br J Pharmacol 2002; 135: 1101-1106.
    CrossrefPubMedGoogle Scholar
  • 60 Amadesi S. et al. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 2004; 24: 4300-4312.
    CrossrefPubMedGoogle Scholar
  • 61 Corvera CU. et al. Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and –2. J Physiol 1999; 517: 741-756.
    CrossrefPubMedGoogle Scholar
  • 62 Narita M. et al. Protease-activated receptor-1 and platelet-derived growth factor in spinal cord neurons are implicated in neuropathic pain after nerve injury. J Neurosci 2005; 25: 10000-10009.
    CrossrefPubMedGoogle Scholar
  • 63 Wu H. et al. The expression and the role of protease nexin-1 on brain edema after intracerebral hemorrhage. J Neurol Sci 2008; 270: 172-183.
    CrossrefPubMedGoogle Scholar
  • 64 Ding-Pfennigdorff D. et al. Stimulation of PAR-2 excites and sensitizes rat cutaneous C-nociceptors to heat. Neuroreport 2004; 15: 2071-2075.
    CrossrefPubMedGoogle Scholar
  • 65 Dai Y. et al. Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J Neurosci 2004; 24: 4293-4299.
    CrossrefPubMedGoogle Scholar
  • 66 Kawabata A. et al. Role of N-methyl-D-aspartate receptors and the nitric oxide pathway in nociception/hyperalgesia elicited by protease-activated receptor-2 activation in mice and rats. Neurosci Lett 2002; 329: 349-353.
    CrossrefPubMedGoogle Scholar
  • 67 Kawabata A. et al. Activation of trigeminal nociceptive neurons by parotid PAR-2 activation in rats. Neuroreport 2004; 15: 1617-1621.
    CrossrefPubMedGoogle Scholar
  • 68 Holzhausen M. et al. Role of protease-activated receptor-2 in inflammation, and its possible implications as a putative mediator of periodontitis. Mem Inst Oswaldo Cruz 2005; 100 (Suppl. 01) 177-180.
    PubMedGoogle Scholar
  • 69 Auge C. et al. Protease-activated receptor-4 (PAR 4): a role as inhibitor of visceral pain and hypersensitivity. Neurogastroenterol Motil 2009; 21: 1189-e107.
    CrossrefPubMedGoogle Scholar
  • 70 Hoogerwerf WA. et al. The proteinase-activated receptor 2 is involved in nociception. J Neurosci 2001; 21: 9036-9042.
    CrossrefPubMedGoogle Scholar
  • 71 Kirkup AJ. et al. Stimulation of proteinase-activated receptor 2 excites jejunal afferent nerves in anaesthetised rats. J Physiol 2003; 552: 589-601.
    CrossrefPubMedGoogle Scholar
  • 72 Vergnolle N. Protease-activated receptors as drug targets in inflammation and pain. Pharmacol Ther 2009; 123: 292-309.
    CrossrefPubMedGoogle Scholar
  • 73 Thiagarajan P. New targets for antithrombotic drugs. Am J Cardiovasc Drugs 2002; 02: 227-235.
    CrossrefPubMedGoogle Scholar
  • 74 Hoogerwerf WA. et al. Trypsin mediates nociception via the proteinase-activated receptor 2: a potentially novel role in pancreatic pain. Gastroenterology 2004; 127: 883-891.
    CrossrefPubMedGoogle Scholar
  • 75 Maeda K. et al. Proinflammatory role of trypsin and protease-activated receptor-2 in a rat model of acute pancreatitis. Pancreas 2005; 31: 54-62.
    CrossrefPubMedGoogle Scholar
  • 76 Hoogerwerf WA. et al. The role of mast cells in the pathogenesis of pain in chronic pancreatitis. BMC Gastroenterol 2005; 05: 8.
    CrossrefPubMedGoogle Scholar
  • 77 Sharma A. et al. Protection against acute pancreatitis by activation of protease-activated receptor-2. Am J Physiol Gastrointest Liver Physiol 2005; 288: G388-395.
    CrossrefPubMedGoogle Scholar
  • 78 Serebruany VL. et al. Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study). Am J Cardiol 2006; 97: 1332-1336.
    CrossrefPubMedGoogle Scholar
  • 79 Paoloni JA, Orchard JW. The use of therapeutic medications for soft-tissue injuries in sports medicine. Med J Aust 2005; 183: 384-388.
    PubMedGoogle Scholar